Device / Technology News

RSS

AI detects daily stress by analyzing routine smartphone behaviors

Clues to stress can be hidden in everyday habits such as chatting, searching, and making payments on a smartphone.

14 Oct 2026

Bulk adverse event reporting may delay medical device safety warnings

Permitting medical device manufacturers to submit bulk summary reports of adverse events to the US Food and Drug Administration (FDA), rather than reporting individual cases, often fails to promptly detect potential safety signals, finds a study published by The BMJ today.

14 Oct 2026

Human accountability remains essential as healthcare adopts AI

With artificial intelligence making deep inroads into healthcare, two top doctors are urging physicians to embrace the technology but to remember that only humans can serve the best interest of individual patients.

14 Oct 2026

New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

A group of scientists led by Joseph Brown, assistant professor at the Leslie Dan Faculty of Pharmacy, has received $2.3 million USD in funding to develop a database and AI training model to identify peptides with therapeutic potential.

14 Oct 2026

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026

Novel bioprinting technique successfully replicates mature human fat tissue

A research team has developed a support-bath bioprinting method that enables fragile, mature human adipocytes to be incorporated into geometrically defined three-dimensional (3D) constructs while retaining their viability, characteristic lipid-filled morphology, and metabolic activity.

14 Oct 2026

New eye model guides lighting designs for aging adults

Researchers have developed a new computational model that accounts for the effects of aging on our eyes' ability to discriminate color.

14 Oct 2026

Seragy launches with €12 million financing to advance quantitative biomarkers for neurodegenerative diseases

seragy holding GmbH (formerly Prosperodes GmbH), a biomarker strategy company focused on neurodegenerative diseases and other proteopathies, has secured €12 million in funding to accelerate the development of its SeRAS® platform (Seed Replication, Analysis and Subtyping) and expand its laboratory and analytical capabilities. The financing is backed by Commerzbank, the Mittelständische Beteiligungsgesellschaft (MBG), and the State of Lower Saxony.

14 Oct 2026

Chemists develop blueprint for designing powerful fluorescent materials for better disease detection

Chemists at the University of Bath have discovered how tiny molecular changes can transform the color and brightness of fluorescent probes based on the blue molecule azulene, paving the way for more powerful imaging tools for detecting diseases such as Alzheimer's, Parkinson’s and cancer.

14 Oct 2026

Enhancing CRISPR analysis with INTEGRA automation

Biotechnology company QUiCKR Bio is using liquid handling solutions from INTEGRA Biosciences to run its CRISPR edit confirmation assays.

From INTEGRA Biosciences 14 Oct 2026

Researchers improve CRISPR technology for detecting HIV and other RNA viruses

Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA. But a different version of the technology, known as Cas13a, targets RNA, the genetic material found in viruses such as HIV.

13 Oct 2026

Charity funds Aston University research into childhood cancer MRI

Aston University's Dr Jan Novak has accepted funding of £45,000 from cancer charity Help Harry Help Others (HHHO) to support a PhD student to research new ways of using MRI scans of children with cancer to better inform their doctors and improve treatment.

13 Oct 2026

Consumer smartwatch helps identify adults with severe sleep apnea

New research suggests that a consumer smartwatch can help identify adults with moderate-to-severe obstructive sleep apnea, offering a way to screen for a common sleep disorder that often goes undiagnosed.

13 Oct 2026

Hybrid AI architecture improves seizure prediction using EEG signals

Epilepsy affects about 50 million people worldwide and can seriously affect patients' quality of life. Electroencephalography (EEG), which records the brain's electrical activity in real time, plays an important role in epilepsy diagnosis and monitoring.

13 Oct 2026

New AI tool distinguishes Ewing sarcoma with high accuracy

A team from the Universitat Politècnica de València (UPV) and the University of Valencia (UV) has developed and validated an artificial intelligence (AI) system capable of distinguishing Ewing sarcoma from other morphologically similar tumours with high accuracy.

13 Oct 2026

Light-activated cotton fabric reduces harmful microorganisms in hospital rooms

A team from the Alcoy campus of the Universitat Politècnica de València (UPV), the Research Institute for Chemical Technology (ITQ, CSIC-UPV), the Research Institute for Mediterranean Agroforestry (IAM UPV) and the Joint Research Unit between the UPV and the Health Research Institute at La Fe Hospital in Valencia (UPV-IISLaFe) has developed a new self-disinfecting cotton fabric capable of eliminating bacteria, fungi and viruses in hospital settings using visible light.

13 Oct 2026

New AI tool detects early psychosis risk in youth speech

Nanyang Technological University, Singapore (NTU Singapore) and the Institute of Mental Health (IMH) have developed a novel artificial intelligence (AI) framework capable of identifying youths at high risk of psychosis - a severe mental health condition that typically emerges in adolescence to early adulthood where a person may experience hallucinations, delusions, and disordered thinking - from short samples of casual, spontaneous speech.

13 Oct 2026

Bedfont® Scientific Ltd. acquires US-based company coVita™, marking the next chapter in its global growth

Bedfont®, a world leader in breath analysis, announces its acquisition of coVita™, building on 16 years of partnership, market knowledge, and established infrastructure to support global expansion.

From Bedfont® Scientific Ltd 13 Oct 2026

Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ in siRNA therapeutic delivery

Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, today announced an oversubscribed $18 million USD seed financing.

From UndecimalBio 13 Oct 2026

Mursla Bio publishes peer-reviewed validation of tissue-specific extracellular vesicle platform for liquid biopsy

Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular Vesicles (impact factor 21.7), the founding journal of the International Society for Extracellular Vesicles. This validates the TS-EV platform for a new class of liquid biopsy: the multiomic disease biology of living cells in a chosen tissue, read from blood, starting with the liver.

From Mursla Bio 13 Oct 2026